It is worth noting that there are numerous Indian-origin brands that compete with foreign brands on a global scale. This includes Indian start-ups that have gone on to disrupt markets in a variety of countries.
Old Monk
For many years, despite any advertising, this Indian brand of rum has been the largest Indian Made Foreign Liquor (IMFL) brand. Mohan Meakin Limited owns Old Monk Rum (OMR), which was launched on December 19, 1954, and is manufactured in Ghaziabad, Uttar Pradesh. With a retail value of 240 million dollars, Old Monk was ranked fifth among Indian spirits brands in Impact International’s 2008 list of “Top 100 Brands at Retail Value.”
Micromax
In the year 2014, this Indian consumer electronics company headquartered in Gurgaon (Haryana) surpassed South Korea’s Samsung by shipping the most phones in a single quarter in India. On January 24, 2014, Micromax, which began as an IT software company in 2000, became the first Indian mobile company to begin sales in Russia.
TATA motors
The Tata group has been international in its approach to business from its inception. The Founder, Jamsetji Nusserwanji Tata, began his business career in international trade in China and England. The businesses he later established in India measured up to international standards and used world-class technology.
Cipla
Cipla has 34 manufacturing units in 8 locations across India and a presence in over 80 countries. Exports accounted for 48% ₹4,948 crore (equivalent to ₹71 billion or US$950 million in 2020) of its revenue for FY 2013–14. Cipla spent ₹517 cr. (5.4% of revenue) in FY 2013–14 on R&D activities. The primary focus areas for R&D were development of new formulations, drug-delivery systems and APIs (active pharmaceutical ingredients). Cipla also cooperates with other enterprises in areas such as consulting, commissioning, engineering, project appraisal, quality control, know-how transfer, support, and plant supply.
Ranbaxy Laboratories
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was founded in 1961 and operated until 2014. In 1973, the company went public. Ranbaxy’s ownership has changed twice in its history.
